Last update :
20/03/2025
Anticancer drug   Dostarlimab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Dostarlimab solution pour perfusion France
Jemperli United States of America
Stability in solutions   injection   Stability in solutions : Dostarlimab     
Container Solvent Concentration Temperature Storage Duration of stability References
Polyvinyl chloride NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
4919
Polyvinyl chloride NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
4919
Polyethylene NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
4919
Polyethylene NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
4919
Polypropylene NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
4919
Polypropylene NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
4919
Polyolefine NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
4919
Polyolefine NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
4919
Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
4919
Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
4919

  Mentions Légales